HawkInsight

  • Contact Us
  • App
  • English

<IPO>CN Biotech Firm Ignis Therapeutics Reportedly Weighing HK IPO

Ignis Therapeutics, a Chinese biotech firm backed by an Abu Dhabi sovereign wealth fund, is weighin...

Ignis Therapeutics, a Chinese biotech firm backed by an Abu Dhabi sovereign wealth fund, is weighing a listing in Hong Kong, Bloomberg reported, citing people with the knowledge of the matter.

The company is working with advisors to prepare for the IPO, with details such as the size and timing still under discussion.


Disclaimer: The views in this article are from the original Creator and do not represent the views or position of Hawk Insight. The content of the article is for reference, communication and learning only, and does not constitute investment advice. If it involves copyright issues, please contact us for deletion.